/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

ABIVAX S.A. Share Price Today: Live Updates & Key Insights

ABIVAX S.A. share price today is $130.93, up 0.72%. The stock opened at $132.225 against the previous close of $130, with an intraday high of $133.52 and low of $130.11.

ABIVAX S.A. Share Price Chart

style
pb-0

ABIVAX S.A.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

ABIVAX S.A. Share Price Performance

$130.93 0.0072(0.72%) ABVX at 10 Aug 2026 05:45 PM Biotechnology
Lowest Today 130.11
Highest Today 133.52
Today’s Open 132.225
Prev. Close 130
52 Week High 148.83
52 Week Low 67.15
Day’s Range: Low 130.11 High 133.52
52-Week Range: Low 67.15 High 148.83
1 day return -
1 Week return +5.0
1 month return -6.92
3 month return +7.15
6 month return +9.28
1 year return +89.81
3 year return +1459.64
5 year return -
10 year return -

ABIVAX S.A. Institutional Holdings

TCG Crossover Management, LLC 7.44

UBS Group AG 5.22

Darwin Global Management, Ltd. 3.98

Morgan Stanley - Brokerage Accounts 1.96

Vestal Point Capital LP 1.72

Caligan Partners LP 1.68

ADAR1 Capital Management LLC 1.60

Westfield Capital Management Company, L.P. 1.52

FMR Inc 1.48

Helikon Investments Ltd 1.16

Eversept Partners, LP 1.07

HHG PLC 1.01

Baker Bros Advisors LP 1.00

Lord, Abbett & Co LLC 0.98

Paradigm Biocapital Advisors LP 0.89

Xtrackers MSCI World Swap ETF 1C 0.87

Cormorant Asset Management, LLC 0.87

Bank of America Corp 0.84

T. Rowe Price Associates, Inc. 0.79

Octagon Capital Advisors LP 0.78

Logos Global Management LP 0.77

iShares Biotechnology ETF 0.55

Lord Abbett Growth Leaders I 0.54

Lord Abbett Growth Leaders SMA 0.54

Eventide Healthcare & Life Sciences I 0.37

HBM Healthcare Investments AG Ord 0.36

Harbor Small Cap Growth Instl 0.34

Westfield Capital Mgt Co Sm-Cap Gr Eq 0.34

Alger Spectra A 0.32

Alger Spectra Composite 0.32

Janus Henderson Hrzn Biotec E2 USD 0.32

Alger Focus Equity Composite 0.30

Alger Focus Equity I 0.30

Westfield Small/Mid Cap Grow Eq CIT CL C 0.28

Worldwide Healthcare Ord 0.25

Franklin Biotechnology Discv A(acc)USD 0.22

abrdn World Healthcare 0.22

abrdn Healthcare Investors 0.22

Lord Abbett Developing Growth A 0.21

Fidelity Growth Compy Commingled Pl S 0.20

ABIVAX S.A. Market Status

Strong Buy: 4

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

ABIVAX S.A. Fundamentals

Market Cap 11330.89 M

PB Ratio 22.0908

PE Ratio 0.0

Enterprise Value 10111.51 M

Total Assets 584.09 M

Volume 1100268

ABIVAX S.A. Company Financials

Annual Revenue FY23:4621000 4.6M, FY22:0 0.0M, FY21:37000 0.0M, FY20:63000 0.1M, FY19:23000 0.0M

Annual Profit FY23:3914000 3.9M, FY22:-110000 -0.1M, FY21:37000 0.0M, FY20:62000 0.1M, FY19:7000 0.0M

Annual Net worth FY23:-147740000 -147.7M, FY22:-69846000 -69.8M, FY21:-41357000 -41.4M, FY20:-37551000 -37.6M, FY19:-30634000 -30.6M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:2017000 2.0M, Q1/2025:0 0.0M, Q4/2023:null 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q3/2025:null 0.0M, Q2/2025:2017000 2.0M, Q1/2025:null 0.0M, Q4/2023:-378000 -0.4M

Quarterly Net worth Q1/2026:-48468000 -48.5M, Q3/2025:-153358000 -153.4M, Q2/2025:-100784000 -100.8M, Q1/2025:-52370000 -52.4M, Q4/2023:-95787000 -95.8M

About ABIVAX S.A. & investment objective

Company Information ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Organisation Biotechnology

Employees 80

Industry Biotechnology

CEO Mr. Marc M. P. de Garidel M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

ABIVAX S.A. FAQs

What is the share price of ABIVAX S.A. today?

The current share price of ABIVAX S.A. is $130.93.

Can I buy ABIVAX S.A. shares in India?

Yes, Indian investors can buy ABIVAX S.A. shares by opening an international trading and demat account with Motilal Oswal.

How to buy ABIVAX S.A. shares in India?

You can easily invest in ABIVAX S.A. shares from India by:

Can I buy fractional shares of ABIVAX S.A.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ABIVAX S.A.?

ABIVAX S.A. has a market cap of $11330.89 M.

In which sector does ABIVAX S.A. belong?

ABIVAX S.A. operates in the Biotechnology sector.

What documents are required to invest in ABIVAX S.A. stocks?

To invest, you typically need:

What is the PE and PB ratio of ABIVAX S.A.?

The PE ratio of ABIVAX S.A. is N/A and the PB ratio is 22.09.